Prospective Single Arm Study on the Effect of Ilaprazole in Patients with Heartburn but No Reflux Esophagitis.

In Ji SongHyun Ki KimNa Keum LeeSang Kil Lee

Published in: Yonsei medical journal (2018)

Daily ilaprazole (20 mg) is efficacious in improving symptom scores, histopathologic findings, and inflammatory biomarkers in patients with heartburn but no reflux esophagitis.

Keyphrases

physical activity
patient reported